Clinical Trial Update: Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether midodrine, octreotide, and albumin can improve renal function in patients with liver cirrhosis and renal failure has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosis
• Hepatorenal Syndrome
• Liver Cirrhosis
• Renal Failure

Drugs mentioned

• Albumin
• Midodrine (Midodrine)
• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Anna Cruceta | Conditions: Fibrosis, Renal Failure | Phase 2 | Status: WITHDRAWN